Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rob van Binnendijk

Showing results (41-50 of 48) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 48 results.
Vaccine|May 15, 2025
What is the current evidence base for measles vaccination earlier than 9 months of age?: Report from an informal technical consultation of the World Health OrganizationAnshu Varma, Shelly Bolotin, Gaston De Serres, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 7, 2022
Antibody and T-Cell Responses 6 Months After Coronavirus Disease 2019 Messenger RNA-1273 Vaccination in Patients With Chronic Kidney Disease, on Dialysis, or Living With a Kidney TransplantJan-Stephan F Sanders, A Lianne Messchendorp, Rory D de Vries, et al.
The Journal of Infection|June 13, 2025
The waning of maternal measles antibodies: a multi-country maternal-infant seroprevalence studyKaren S Tiley, Hinke Ten Hulscher-van Overbeek, Sudha Basnet, et al.
The Lancet. Infectious Diseases|November 10, 2022
Alternative strategies to increase the immunogenicity of COVID-19 vaccines in kidney transplant recipients not responding to two or three doses of an mRNA vaccine (RECOVAC): a randomised clinical trialMarcia M L Kho, A Lianne Messchendorp, Sophie C Frölke, et al.
NPJ Vaccines|January 3, 2024
Immunogenicity and reactogenicity of intradermal mRNA-1273 SARS-CoV-2 vaccination: a non-inferiority, randomized-controlled trialManon L M Prins, Geert V T Roozen, Cilia R Pothast, et al.
Transplantation|November 10, 2021
The RECOVAC Immune-response Study: The Immunogenicity, Tolerability, and Safety of COVID-19 Vaccination in Patients With Chronic Kidney Disease, on Dialysis, or Living With a Kidney TransplantJan-Stephan F Sanders, Frederike J Bemelman, A Lianne Messchendorp, et al.
Emerging Infectious Diseases|February 8, 2007
Identical genotype B3 sequences from measles patients in 4 countries, 2005Jennifer Rota, Luis Lowe, Paul Rota, et al.
Emerging Infectious Diseases|February 9, 2008
High genetic diversity of measles virus, World Health Organization European Region, 2005-2006Jacques R Kremer, Kevin E Brown, Li Jin, et al.
Pageof 5

Showing results (41-50 of 48) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 48 results.
Vaccine|May 15, 2025
What is the current evidence base for measles vaccination earlier than 9 months of age?: Report from an informal technical consultation of the World Health OrganizationAnshu Varma, Shelly Bolotin, Gaston De Serres, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 7, 2022
Antibody and T-Cell Responses 6 Months After Coronavirus Disease 2019 Messenger RNA-1273 Vaccination in Patients With Chronic Kidney Disease, on Dialysis, or Living With a Kidney TransplantJan-Stephan F Sanders, A Lianne Messchendorp, Rory D de Vries, et al.
The Journal of Infection|June 13, 2025
The waning of maternal measles antibodies: a multi-country maternal-infant seroprevalence studyKaren S Tiley, Hinke Ten Hulscher-van Overbeek, Sudha Basnet, et al.
The Lancet. Infectious Diseases|November 10, 2022
Alternative strategies to increase the immunogenicity of COVID-19 vaccines in kidney transplant recipients not responding to two or three doses of an mRNA vaccine (RECOVAC): a randomised clinical trialMarcia M L Kho, A Lianne Messchendorp, Sophie C Frölke, et al.
NPJ Vaccines|January 3, 2024
Immunogenicity and reactogenicity of intradermal mRNA-1273 SARS-CoV-2 vaccination: a non-inferiority, randomized-controlled trialManon L M Prins, Geert V T Roozen, Cilia R Pothast, et al.
Transplantation|November 10, 2021
The RECOVAC Immune-response Study: The Immunogenicity, Tolerability, and Safety of COVID-19 Vaccination in Patients With Chronic Kidney Disease, on Dialysis, or Living With a Kidney TransplantJan-Stephan F Sanders, Frederike J Bemelman, A Lianne Messchendorp, et al.
Emerging Infectious Diseases|February 8, 2007
Identical genotype B3 sequences from measles patients in 4 countries, 2005Jennifer Rota, Luis Lowe, Paul Rota, et al.
Emerging Infectious Diseases|February 9, 2008
High genetic diversity of measles virus, World Health Organization European Region, 2005-2006Jacques R Kremer, Kevin E Brown, Li Jin, et al.
Pageof 5